Study Stopped
Grant ended
A 3D Hydrogel Model to Assess Endothelial Cell-macrophage Interactions in Simulated Microgravity (OR-DRPD-SRI2019)
OR-DRPD-SRI2019: A 3D Hydrogel Model to Assess Endothelial Cell-macrophage Interactions in Simulated Microgravity
3 other identifiers
observational
N/A
0 countries
N/A
Brief Summary
The proposal contained herein seeks to examine the effect of simulated microgravity on important cell-cell interactions that govern vascular health. The interest lies in endothelial cell (EC) and macrophage cell interactions. The investigators are proposing to first understand how microgravity effects the macrophage and EC function or pro-healing capabilities. Next, the study team plans to develop a 3D tissue regeneration model in which macrophages and ECs are co-cultured in a hydrogel matrix. Utilizing this model, the team will assess how microgravity influenced macrophage-EC interactions in 3D. The investigators will assess EC tubule volume (or blood vessel development), macrophage spreading and the interactions with endothelial tubule sprouts. This model will serve as a critical foundation for future grant opportunities as it allows the assessment of tissue regeneration and vascular health in a 3D tissue microenvironment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2021
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 19, 2019
CompletedFirst Posted
Study publicly available on registry
July 23, 2019
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2021
CompletedAugust 2, 2021
July 1, 2021
Same day
July 19, 2019
July 26, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Isolate macrophages
Isolation of circulating immune cells, termed macrophages from whole blood. The study team will isolate the macrophages that are contained within the peripheral blood mononuclear cell fraction (PBMNC). The investigators expect to isolate 800,000-3,200,000 PBMNC per ml of blood. The isolated cells will then be subject to culture in a simulated microgravity device.
within 4 hours of blood collection
Study Arms (1)
Males and females
The investigators are interested in sampling a wide variety of individuals from varying ethnic groups, sex, and age range.
Interventions
The subject will be sitting in a chair, and a needle will be inserted into a vein in the arm. Study Team will draw about 45ml or 3 tablespoons of whole blood for research.
Eligibility Criteria
General population between 21-50 years old.
You may qualify if:
- Self-reported healthy individuals
- Willingness to have 50mls of whole blood collected
You may not qualify if:
- Unwillingness to have blood used in microgravity study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- Florida Space Institutecollaborator
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Josephine Allen, Ph.D.
University of Florida
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2019
First Posted
July 23, 2019
Study Start
June 1, 2021
Primary Completion
June 1, 2021
Study Completion
June 1, 2021
Last Updated
August 2, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share
Data obtained will be disseminated through publications and conference presentations. No subject data will be shared with other researchers.